the fed is doing everything to free up hospital resources and bending rules to make things work... both the darzalex and roche sc versions of their drugs do that ... free up hours per patient for an IV... and they would keep compromised patints away from hospital settings.... basically a low risk decision to give early approval... both passed phase 3's with flying colors and actually reduced infusion reactions... these are not elective drugs for cancer patients... would be surprised if action not taken soon... all imo...
News 
Market Data 
Discover 
AI
